SEC Form 4 · accession 0001754129-26-000006
Design Therapeutics, Inc. · DSGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin D. Gover
Director
Period of report
Jun 9, 2026
Accepted (ET)
Jun 11, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001807120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.55 | Jun 9, 2026 | A | 30,000 | A | — | Jun 8, 2036 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.